ProKyma is based on Dstl’s proprietary ultrasound technology for manipulating particles.

Sensitive detection methods are limited by the purity of the starting material. Techniques are available to purify and concentrate biological specimens but these methods are often labour intensive or only partly effective. Major improvements in analysing biological samples such as bacteria, cells and DNA require improved sample preparation. ProKyma’s Sonic Separation technology provides a means for concentrating and purifying cells or micro-organisms. Sonic Separation can also be used to isolate or analyse cell aggregates, for example in blood grouping and serology.

Status exits

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

MoD Spin-Out Receives Funding For Technology That Promises Improved Earlier Detection And Treatment of Cancer

November 29, 2012: ProKyma, a spin-out from the Defence Science and Technology Laboratory (Dstl), today…

read more

More Companies in Medical / Biotechnology